| 9-OR: ADA Presidents' Select Abstract: Targeting Inflammation with Salsalate in Type 1 Diabetes Neuropathy (TINSAL-T1DN Trial) L ANG, Y HUANG, C MARTIN, KR MIZOKAMI-STOUT, YU KUEI LIN, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study A Chalkias, Y Huang, A Ismail, I Pantazopoulos, N Papagiannakis, ... Critical Care Medicine 52 (6), 930-941, 2024 | | 2024 |
| Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19 SN Goonewardena, Q Chen, AM Tate, OG Grushko, D Damodaran, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (5), 1124-1134, 2024 | | 2024 |
| Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study CG Hutten, K Padalia, A Vasbinder, Y Huang, A Ismail, I Pizzo, ... The Journal of Clinical Endocrinology & Metabolism, dgae273, 2024 | | 2024 |
| Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American … SS Hayek, VG Zaha, C Bogle, A Deswal, A Langston, S Rotz, A Vasbinder, ... Circulation 149 (16), e1113-e1127, 2024 | | 2024 |
| OBESITY, INFLAMMATION AND CLINICAL OUTCOMES IN COVID-19: PRE-AND POST-OMICRON C Hutten, K Padalia, A Vasbinder, Y Huang, A Ismail, I Pizzo, KM Diaz, ... Journal of the American College of Cardiology 83 (13_Supplement), 1970-1970, 2024 | | 2024 |
| EXPOSURE OF HUMAN DERIVED MACROPHAGES TO SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR DECREASES THEIR PHAGOCYTIC ABILITY A Ismail, GK Erne, F Presswalla, C Hutten, KM Diaz, T Catalan, I Pizzo, ... Journal of the American College of Cardiology 83 (13_Supplement), 1305-1305, 2024 | | 2024 |
| A VALIDATED BIOMARKER RISK SCORE ENHANCES CARDIOVASCULAR ASSESSMENT IN PATIENTS WITH CORONARY ARTERY DISEASE M Gold, YA Ko, Y Chen, X Chen, D Gold, V Jain, N Vatsa, S Desai, C Liu, ... Journal of the American College of Cardiology 83 (13_Supplement), 1269-1269, 2024 | | 2024 |
| Incidence of Immune Checkpoint Inhibitor–Induced Myocarditis During the COVID‐19 Pandemic A Vasbinder, E Anderson, T Catalan, A Ismail, M Banerjee, I Pizzo, ... Journal of the American Heart Association 13 (6), e032667, 2024 | | 2024 |
| Residential Address Amplifies Health Disparities and Risk of Infection in Individuals With Diabetic Foot Ulcers BM Schmidt, Y Huang, M Banerjee, SS Hayek, R Pop-Busui Diabetes Care 47 (3), 508-515, 2024 | | 2024 |
| Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ... Nature Medicine 30 (3), 910-910, 2024 | | 2024 |
| Reply: Addressing the Overlooked: Orthostatic Intolerance Syndromes in Hematopoietic Stem Cell Transplant Recipients A Vasbinder, S Hayek Cardio Oncology 6 (1), 141-141, 2024 | | 2024 |
| Survival Characteristics of Older Patients Hospitalized With COVID-19: Insights From the American Heart Association COVID-19 Cardiovascular Disease Registry RY Yeow, MP O’Leary, AR Reddy, NS Kamdar, SS Hayek, JA de Lemos, ... Journal of the American Medical Directors Association 25 (2), 348, 2024 | | 2024 |
| Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023) C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ... NATURE MEDICINE, 2024 | | 2024 |
| Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score A Vasbinder, T Catalan, E Anderson, C Chu, M Kotzin, D Murphy, ... Journal of the American Heart Association 13 (1), e033599, 2024 | 1 | 2024 |
| Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity JR Power, C Dolladille, A Procureur, SR Ederhy, NL Palaskas, ... medRxiv, 2024.06. 02.24308336, 2024 | | 2024 |
| Biomarkers of chronic inflammation and cognitive decline: A prospective observational study BA Guduguntla, A Vasbinder, E Anderson, TU Azam, P Blakely, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 16 (1 …, 2024 | | 2024 |
| SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19 A Vasbinder, K Padalia, I Pizzo, K Machado, T Catalan, F Presswalla, ... Journal of Medical Virology 96 (1), e29389, 2024 | 2 | 2024 |
| Immune activation mediates the Association of Advanced Hepatic Fibrosis with Adverse Outcomes in patients with coronary artery disease V Jain, A Mehta, TB Lee, C Liu, NWS Chew, YA Ko, ME Gold, DA Gold, ... Journal of the American Heart Association 12 (24), e031230, 2023 | 1 | 2023 |
| Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ... Nature Medicine 29 (12), 3268-3268, 2023 | | 2023 |
Arshed A Quyyumi, MDEmory University School of Medicine在 emory.edu 的电子邮件经过验证
